Key Market Segments
By Product
-
Infusion Pumps
-
Intravenous Sets
-
IV Cannulas
-
Needleless Connectors
By Application
-
Anti-Infective
-
Endocrinology
-
Chemotherapy
-
Enteral Nutrition
-
Parenteral Nutrition
-
Others
By Route of Administration
-
Intramuscular
-
Subcutaneously
-
Epidural

Request for Segment Customization as per your Business Requirement: Segment Customization Request
Regional Coverage:
North America
-
US
-
Canada
-
Mexico
Europe
-
Eastern Europe
-
Poland
-
Romania
-
Hungary
-
Turkey
-
Rest of Eastern Europe
-
-
Western Europe
-
Germany
-
France
-
UK
-
Italy
-
Spain
-
Netherlands
-
Switzerland
-
Austria
-
Rest of Western Europe
-
Asia Pacific
-
China
-
India
-
Japan
-
South Korea
-
Vietnam
-
Singapore
-
Australia
-
Rest of Asia Pacific
Middle East & Africa
-
Middle East
-
UAE
-
Egypt
-
Saudi Arabia
-
Qatar
-
Rest of the Middle East
-
-
Africa
-
Nigeria
-
South Africa
-
Rest of Africa
-
Latin America
-
Brazil
-
Argentina
-
Colombia
-
Rest of Latin America
Request for Country Level Research Report: Country Level Customization Request
Available Customization
-
With the given market data, SNS Insider offers customization as per the company’s specific needs. The following customization options are available for the report:
-
Product Analysis
-
Criss-Cross segment analysis (e.g. Product X Application)
-
Product Matrix which gives a detailed comparison of the product portfolio of each company
-
Geographic Analysis
-
Additional countries in any of the regions
-
Company Information
-
Detailed analysis and profiling of additional market players (Up to five)
Frequently Asked Questions
Ans: The major key players are CVS/Coram, BD, Option Care Health, Baxter, Smith’s Medical, B Braun Melsungen Ag, JMS Corp Ltd, Terumo Corp. and others.
Ans: Patients who require home infusion therapy treatments may have less access to care as a result of a downturn in the industry.
Ans: North America region will dominate the market.
Ans: The Home Infusion Therapy Market Size was valued at USD 35.98 Billion in 2023 and is expected to reach USD 71.82 Billion by 2032 and grow at a CAGR of 8.36% over the forecast period 2024-2032
Ans: The rising healthcare expenses and the government support supportive actions for the home infusion therapy.